Literature DB >> 24247424

Prostate cancer: Antisense nucleic acids--tough delivery.

Mina Razzak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24247424     DOI： 10.1038/nrurol.2013.271

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.

Authors:  D Bianchini; A Omlin; C Pezaro; D Lorente; R Ferraldeschi; D Mukherji; M Crespo; I Figueiredo; S Miranda; R Riisnaes; A Zivi; A Buchbinder; D E Rathkopf; G Attard; H I Scher; J de Bono; D C Danila
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.